1. Home
  2. TSHA vs TMC Comparison

TSHA vs TMC Comparison

Compare TSHA & TMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • TMC
  • Stock Information
  • Founded
  • TSHA 2019
  • TMC 2011
  • Country
  • TSHA United States
  • TMC Canada
  • Employees
  • TSHA N/A
  • TMC N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • TMC Metal Mining
  • Sector
  • TSHA Health Care
  • TMC Basic Materials
  • Exchange
  • TSHA Nasdaq
  • TMC Nasdaq
  • Market Cap
  • TSHA 403.7M
  • TMC 340.2M
  • IPO Year
  • TSHA 2020
  • TMC N/A
  • Fundamental
  • Price
  • TSHA $2.06
  • TMC $1.00
  • Analyst Decision
  • TSHA Strong Buy
  • TMC Hold
  • Analyst Count
  • TSHA 8
  • TMC 1
  • Target Price
  • TSHA $6.63
  • TMC $4.00
  • AVG Volume (30 Days)
  • TSHA 6.0M
  • TMC 844.6K
  • Earning Date
  • TSHA 11-13-2024
  • TMC 11-14-2024
  • Dividend Yield
  • TSHA N/A
  • TMC N/A
  • EPS Growth
  • TSHA N/A
  • TMC N/A
  • EPS
  • TSHA N/A
  • TMC N/A
  • Revenue
  • TSHA $9,915,000.00
  • TMC N/A
  • Revenue This Year
  • TSHA N/A
  • TMC N/A
  • Revenue Next Year
  • TSHA N/A
  • TMC N/A
  • P/E Ratio
  • TSHA N/A
  • TMC N/A
  • Revenue Growth
  • TSHA N/A
  • TMC N/A
  • 52 Week Low
  • TSHA $1.19
  • TMC $0.80
  • 52 Week High
  • TSHA $4.32
  • TMC $2.07
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 55.32
  • TMC 50.89
  • Support Level
  • TSHA $1.19
  • TMC $0.92
  • Resistance Level
  • TSHA $2.63
  • TMC $0.99
  • Average True Range (ATR)
  • TSHA 0.24
  • TMC 0.05
  • MACD
  • TSHA 0.08
  • TMC 0.00
  • Stochastic Oscillator
  • TSHA 60.42
  • TMC 68.18

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About TMC TMC the metals company Inc.

TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Geographically, the company has its presence in Nauru, Singapore, Tonga and North America. The CCZ is a geological submarine fracture zone of abyssal plains and other formations in the Eastern Pacific Ocean, with a length of around 7,240 kilometers (4,500 miles) that spans approximately 4,500,000 square kilometers (1,700,000 square miles).

Share on Social Networks: